# Predictive Impact of Circulating Vascular Endothelial Growth Factor in Four Phase III Trials Evaluating Bevacizumab

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/predictive-impact-of-circulating-vascular-endothelial-growth-factor-in-four/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Priti S. Hegde,Adrian M. Jubb,Dafeng Chen,Nicole F. Li,Yong Meng,Coen Bernaards,Rebecca Elliott,Stefan Scherer,Daniel S. Chen |
| Citations | 194 |
| DOI | 10.1158/1078-0432.ccr-12-2535 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2096396175 |
| PMID | 23169435 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Coen Bernaards](https://scholariq.org/researchers/coen-bernaards/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)

## Paper topics

- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Lymphatic System and Diseases](https://scholariq.org/topics/lymphatic-system-and-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.